704 related articles for article (PubMed ID: 30691855)
21. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
22. LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice.
Li C; Yang D; Cao X; Wang F; Jiang H; Guo H; Du L; Guo Q; Yin X
Biochem Pharmacol; 2016 Aug; 113():57-69. PubMed ID: 27206337
[TBL] [Abstract][Full Text] [Related]
23. Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice.
Chen Y; Guo S; Jiang K; Wang Y; Yang M; Guo M
Int Immunopharmacol; 2019 Oct; 75():105749. PubMed ID: 31306981
[TBL] [Abstract][Full Text] [Related]
24. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
25. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
[TBL] [Abstract][Full Text] [Related]
27. Topotecan alleviates ventilator-induced lung injury via NF-κB pathway inhibition.
Wan B; Xu WJ; Zhan P; Jin JJ; Xi GM; Chen MZ; Hu YB; Zhu SH; Liu HB; Wang XX; Zhang XW; Lv TF; Song Y
Cytokine; 2018 Oct; 110():381-388. PubMed ID: 29803659
[TBL] [Abstract][Full Text] [Related]
28. Dapk1 improves inflammation, oxidative stress and autophagy in LPS-induced acute lung injury via p38MAPK/NF-κB signaling pathway.
Li T; Wu YN; Wang H; Ma JY; Zhai SS; Duan J
Mol Immunol; 2020 Apr; 120():13-22. PubMed ID: 32045770
[TBL] [Abstract][Full Text] [Related]
29. Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1-CX3CR1 axis and NF-κB pathway in CX3CL1-knockout mice.
Ding XM; Pan L; Wang Y; Xu QZ
Int J Mol Med; 2016 Mar; 37(3):703-15. PubMed ID: 26782291
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
31. Overexpressing six-transmembrane protein of prostate 2 (STAMP2) alleviates sepsis-induced acute lung injury probably by hindering M1 macrophage polarization via the NF-κB pathway.
Ji L; Shi X; Wang G; Wu H; Hu Z
Folia Histochem Cytobiol; 2023; 61(1):34-46. PubMed ID: 36583372
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice.
Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573
[TBL] [Abstract][Full Text] [Related]
33. Biochanin A protect against lipopolysaccharide-induced acute lung injury in mice by regulating TLR4/NF-κB and PPAR-γ pathway.
Hu X; Qin H; Li Y; Li J; Fu L; Li M; Jiang C; Yun J; Liu Z; Feng Y; Yao Y; Yin B
Microb Pathog; 2020 Jan; 138():103846. PubMed ID: 31698051
[TBL] [Abstract][Full Text] [Related]
34. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
Jing W; Chunhua M; Shumin W
Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
[TBL] [Abstract][Full Text] [Related]
35. Quietness of circular RNA circ_0054633 alleviates the inflammation and proliferation in lipopolysaccharides-induced acute lung injury model through NF-κB signaling pathway.
Yang CL; Yang WK; He ZH; Guo JH; Yang XG; Li HB
Gene; 2021 Jan; 766():145153. PubMed ID: 32950633
[TBL] [Abstract][Full Text] [Related]
36. [Multiple components of Mahuang Shengma Decoction on prevention and treatment of acute lung injury based on RAGE/NF-κB signaling pathway].
Ma YM; Zhao LJ; Liu MR; Liang K; Song B; Bai SX; Li ZY; Chai Z; Peng T
Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(21):5693-5700. PubMed ID: 34951223
[TBL] [Abstract][Full Text] [Related]
37. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
38. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
39. PIM1 inhibitor SMI-4a attenuated lipopolysaccharide-induced acute lung injury through suppressing macrophage inflammatory responses via modulating p65 phosphorylation.
Wang J; Cao Y; Liu Y; Zhang X; Ji F; Li J; Zou Y
Int Immunopharmacol; 2019 Aug; 73():568-574. PubMed ID: 31203114
[TBL] [Abstract][Full Text] [Related]
40. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI.
Cai J; Wang YL; Sheng XD; Zhang L; Lv X
J Ethnopharmacol; 2022 Nov; 298():115661. PubMed ID: 36002086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
